Integer Holdings Corporation (NYSE:ITGR - Get Free Report) has earned an average recommendation of "Hold" from the ten research firms that are currently covering the firm, MarketBeat.com reports. Six investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $102.00.
Several analysts have recently weighed in on ITGR shares. Citigroup lifted their target price on shares of Integer from $75.00 to $92.00 and gave the company a "neutral" rating in a report on Friday, February 20th. Raymond James Financial restated an "outperform" rating and issued a $101.00 price objective on shares of Integer in a research report on Monday, February 23rd. Wells Fargo & Company lifted their price objective on Integer from $72.00 to $84.00 and gave the company an "equal weight" rating in a report on Friday, February 20th. Truist Financial boosted their target price on Integer from $95.00 to $97.00 and gave the stock a "buy" rating in a research report on Friday, February 20th. Finally, Wall Street Zen downgraded Integer from a "buy" rating to a "hold" rating in a research note on Sunday, January 25th.
Read Our Latest Stock Report on ITGR
Integer Trading Down 0.9%
NYSE:ITGR opened at $87.80 on Thursday. Integer has a 12-month low of $62.00 and a 12-month high of $127.56. The company has a current ratio of 3.32, a quick ratio of 2.23 and a debt-to-equity ratio of 0.69. The stock's 50 day simple moving average is $85.91 and its 200-day simple moving average is $82.91. The firm has a market cap of $2.99 billion, a P/E ratio of 30.59, a PEG ratio of 1.50 and a beta of 0.71.
Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings data on Thursday, February 19th. The medical equipment provider reported $1.76 earnings per share for the quarter, beating analysts' consensus estimates of $1.70 by $0.06. The firm had revenue of $472.06 million for the quarter, compared to analyst estimates of $462.73 million. Integer had a net margin of 5.55% and a return on equity of 13.26%. Integer's quarterly revenue was up 5.0% on a year-over-year basis. During the same period last year, the firm posted $1.43 EPS. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. Equities analysts anticipate that Integer will post 6.01 EPS for the current year.
Insider Transactions at Integer
In other Integer news, VP Tommy P. Thomas sold 825 shares of the stock in a transaction on Friday, March 13th. The stock was sold at an average price of $85.00, for a total value of $70,125.00. Following the completion of the transaction, the vice president owned 4,381 shares in the company, valued at approximately $372,385. This represents a 15.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 2.16% of the company's stock.
Hedge Funds Weigh In On Integer
A number of large investors have recently made changes to their positions in ITGR. Salomon & Ludwin LLC grew its stake in Integer by 46.8% during the 4th quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider's stock worth $29,000 after buying an additional 118 shares during the last quarter. Kestra Advisory Services LLC lifted its stake in Integer by 0.6% in the fourth quarter. Kestra Advisory Services LLC now owns 21,424 shares of the medical equipment provider's stock valued at $1,680,000 after buying an additional 136 shares during the last quarter. Orion Porfolio Solutions LLC boosted its holdings in shares of Integer by 1.4% during the second quarter. Orion Porfolio Solutions LLC now owns 9,755 shares of the medical equipment provider's stock valued at $1,200,000 after acquiring an additional 138 shares during the period. Lido Advisors LLC grew its position in shares of Integer by 5.5% during the fourth quarter. Lido Advisors LLC now owns 2,887 shares of the medical equipment provider's stock worth $226,000 after acquiring an additional 151 shares during the last quarter. Finally, Heritage Family Offices LLP grew its position in shares of Integer by 4.9% during the third quarter. Heritage Family Offices LLP now owns 3,443 shares of the medical equipment provider's stock worth $356,000 after acquiring an additional 160 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.
Integer Company Profile
(
Get Free Report)
Integer Holdings Corporation NYSE: ITGR is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.
Integer's product portfolio is organized into two core segments: Advanced Delivery and MedTech.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.